NUBURU, Inc., a Leading Innovator in High Power and High Brightness Industrial Blue Laser Technology, to Go Public Through Merger With Tailwind Acquisition Corp.
NUBURU, Inc. (“NUBURU”) has entered into a business combination agreement with Tailwind Acquisition Corp. (“TWND”)
Brancieri joins NTx to oversee cGMP certification for the manufacturing and distribution of platform raw materials
GreenSpur Wind and Niron Magnetics Collaborate to Develop New Rare Earth-free Generator Solution for the Offshore Wind Market
GreenSpur designed a new, rare earth-free 15MW generator based on Niron’s magnet technology that delivers a 56% reduction in mass and meets required efficiency targets
Jimmy’s promotion to Partner is a reflection of the years of hard work and passion he has put into his role as a key member of our investment team here at Anzu Partners
Ron Dizy brings over 25 years of energy industry leadership across strategy, finance, operations, engineering, and business development to e-Zinc’s board
InterVenn Expands Global Presence to Drive the Potential of Glycoproteomics to Improve Patient Outcomes
The company’s new facilities add a large footprint of state-of-the-art laboratories and office space for scaling up InterVenn’s software development, technical support, clinical research and business development.
Nathan Duval, PhD, Lead Scientist, will present at the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) National Meeting
Following its Series A financing, BioFlyte welcomes national security and public safety executive Todd Sickles as CEO to accelerate productization and market penetration of its disruptive biodetection technology
Aspinity AML100 Solution Delivers Industry’s Best Battery Life/Accuracy Combo for Glass Break Sensors
Aspinity’s power-intelligent analogML solution named 2022 Best of Sensors Awards finalist
Fluent BioSciences and NanoCellect announce joint collaboration to improve resolution of single-cell RNA sequencing analysis of rare cell populations
Fluent and NanoCellect are able to leverage and combine the unique advantages of our respective technologies to expand the use of single-cell RNA sequencing for rare cell populations.